Sun Pharmaceutical Industries Limited has informed the Exchange about newspaper publication for special window for transfer of physical shares
SUNPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
SEBI has opened a special window from 05 February 2026 to 04 February 2027 for transfer of physical shares that were sold/purchased before 01 April 2019. This includes previously rejected, returned, or unattended transfer requests. Sun Pharma published newspaper advertisements on 20 May 2026 (Financial Express English and Gujarati editions) informing investors about this facility. Transferred securities will be credited only in demat mode and will be under a one-year lock-in from the date of transfer registration, during which they cannot be transferred, lien-marked, or pledged. Investors must submit documents including original share certificates, transfer deeds executed before April 2019, KYC documents, and client master list to the RTA MUFG Intime India Private Limited.
This is a routine compliance filing informing investors about a SEBI-mandated facility. It has no direct impact on Sun Pharma's financial performance or stock price. Physical shareholders who wish to convert holdings to demat form can now do so under this window.